VK Sharma, Head - PCG and Capital Market Strategy at HDFC Securities suggests buying Titan Company, Eicher Motors, Biocon, Dr Reddy's Labs and IDFC.
Sudarshan Sukhani of s2analytics.com is of the view that one can buy L&T, Asian Paints, Whirlpool of India, Sun TV Network and Bajaj Finance and advises selling Ajanta Pharma and Dish TV.
Mitessh Thakkar of mitesshthakkar.com is of the view that one can buy Balkrishna Industries, Exide Industries, Granules India and Just Dial and sell Repco Home Finance.
Biocon on Monday said it received zero observations for its active pharmaceutical ingredient (API) plant in Visakhapatnam, Andhra Pradesh.
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Ashok Leyland, Biocon and Hindalco Industries and sell Castrol India.
The Bengaluru-based firm, which has been chasing the target since 2011, has identified these verticals as its key focus areas. Biocon had posted a revenue of Rs 4,078.7 crore in 2016-17.
The Europe GMP compliance certificate helps Biocon insulin, particularly insulin glargine to gain entry into the highly regulated Europe market.
Ashwani Gujral of ashwanigujral.com suggests buying Eicher Motors on every dip.
Small booster for Biocon as they have received a certificate of good manufacturing practices (GMP) compliance from the European regulator for its insulin manufacturing facility in Malaysia.
According to Prakash Gaba of prakashgaba.com, crucial support for the Nifty is at 9840 and the resistance is at 10005-10050. Bank Nifty on the other hand has support at 24100 and resistance at 24511.
The facility was inspected by Irish drug regulator HPRA as the representative European inspection authority in April 2017.
As per the agreement – JDRF or Juvenile Diabetes Research Foundation as it was known will fund Biocon’s global multiple ascending dose study of oral insulin drug candidate to evaluate the safety and tolerability in people with type 1 diabetes.
Kochi-based investor Porinju Veliyath's journey from an investor to Equity Intelligence, his firm which managed over Rs 1,200 crore worth of portfolio.
Mitessh Thakkar of mitesshthakkar.com is of the view that one can buy Container Corporation of India, Indian Oil Corporation, Essel Propack and Godrej Properties and sell Mahindra and Mahindra.
Moneycontrol spoke to Narendra Chirmule, Senior Vice President and Head of Biocon, R&D to find out what this means to the company's hope to launch first ever Trastuzumab biosimilar in US market.
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Adani Ports and Jubilant Foodworks and can hold Biocon while one can sell Exide Industries.
Sudarshan Sukhani of s2analytics.com is of the view that one can buy TVS Motor Company, Maruti Suzuki, Tata Steel, Siemens and Bharat Forge and can sell SRF.
Axis Direct is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 380 in its research report dated 23 August 2017.
Rahul Shah of Motilal Oswal is of the view that one can buy JSW Steel and Dewan Housing Finance and short Biocon.
Sudarshan Sukhani of s2analytics.com is of the view that one can sell PVR and Bank of Baroda and buy Bharti Airtel and Ashok Leyland while one may hold ICICI Bank.
Ashwani Gujral of ashwanigujral.com suggests buying BPCL, Gruh Finance and United Spirits.
According to Sudarshan Sukhani of s2analytics.com, one can buy Yes Bank, Hindustan Zinc and Indraprastha Gas and sell Apollo Hospitals Enterprises while one can avoid HDIL.
“The request for withdrawal of the dossiers and re-submission is part of EMA procedural requirements linked to this re-inspection and will be considered by the EMA’s Committee for Medicinal Products of Human Use (CHMP),” the company said.
"While our drug substance facilities for Trastuzumab and Pegfilgrastim were approved, the European regulatory authorities had informed us of the need for a re-inspection of our drug product facility for these products," the bio- pharmaceutical firm said in a regulatory filing.
Ashwani Gujral of ashwanigujral.com recommends selling Biocon, Ceat and Adani Enterprises.